Related references
Note: Only part of the references are listed.Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants
David J. Seiffge et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
AF-React study: atrial fibrillation management strategies in clinical practice-retrospective longitudinal study from real-world data in Northern Portugal
Susana Silva Pinto et al.
BMJ OPEN (2021)
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017
Lina Wang et al.
HEART (2021)
Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatment
Andrew K. ElHabr et al.
BMJ NEUROLOGY OPEN (2021)
Predictive value of discharge destination for 90-day outcomes among ischemic stroke patients eligible for endovascular treatment: Post-hoc analysis of DEFUSE 3
Ganesh Asaithambi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation
Lisa Hert et al.
EUROPEAN STROKE JOURNAL (2020)
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
H. -C. Diener et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study
Maurizio Paciaroni et al.
STROKE (2019)
Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration
Adam J. Rose et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
R. G. Hart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Incidence and functional outcome of atrial fibrillation and non-atrial fibrillation-related cardioembolic stroke in Joinville, Brazil: a population-based study
Claudio Henrique do Amaral et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2017)
Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes
Nils Henninger et al.
STROKE (2016)
Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk Insights From the NCDR PINNACLE Registry
Jonathan C. Hsu et al.
JAMA CARDIOLOGY (2016)
Atrial fibrillation: prevalence in a large database of primary care patients in Brazil
Milena S. Marcolino et al.
EUROPACE (2015)
Prevalence of oral anticoagulation in atrial fibrillation
Eduardo Bartholomay et al.
CLINICS (2014)
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population
Susan Colilla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Oral anticoagulants and non-cardioembolic stroke prevention
Michael E. Schachter et al.
VASCULAR MEDICINE (2008)
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
Yoko Miyasaka et al.
CIRCULATION (2006)
Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study)
J Friberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
A Evans et al.
STROKE (2001)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies
RG Hart et al.
CEREBROVASCULAR DISEASES (2000)
Share Paper
